ASSOCIATION BETWEEN POLYMORPHISMS OF RFC1 GENE AND HIGH-DOSE METHOTREXATE THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Yang, J. [1 ]
Jiang, H. [1 ]
Li, H. [1 ]
机构：
[1] Shanghai Childrens Hosp, Shanghai 200040, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-022
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [1] THE RESEARCH OF THE RELATIONSHIP BETWEEN RFC1A80G GENETIC POLYMORPHISMS AND HIGH-DOSE METHOTREXATE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Hong, L.
    Hui, J.
    Qin, L.
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 : 55 - 55
  • [2] The Association Between Plasma Methotrexate Concentration and Genetic Variant in High-dose Methotrexate Therapy for Childhood Acute Lymphoblastic Leukemia
    Tanaka, Yoichi
    Urayama, Kevin
    Mori, Makiko
    Hasegawa, Daisuke
    Akahane, Koshi
    Ota, Setsuo
    Koh, Katsuyoshi
    Manabe, Atsushi
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S97 - S98
  • [3] Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia
    L Huang
    W J E Tissing
    R de Jonge
    B D van Zelst
    R Pieters
    [J]. Leukemia, 2008, 22 : 1798 - 1800
  • [4] Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia
    Huang, L.
    Tissing, W. J. E.
    de Jonge, R.
    van Zelst, B. D.
    Pieters, R.
    [J]. LEUKEMIA, 2008, 22 (09) : 1798 - 1800
  • [5] The effect of the plasma methotrexate concentration during high-dose methotrexate therapy in childhood acute lymphoblastic leukemia
    Liao, Chan
    Nie, Jing
    Xu, Xiao-Jun
    Zhang, Jing-Ying
    Xu, Wei-Qun
    Song, Hua
    Shen, He-Ping
    Shen, Di-Ying
    Zhao, Fen-Ying
    Liang, Juan
    Miao, Jing
    Tang, Yong-Min
    [J]. LEUKEMIA & LYMPHOMA, 2024, 65 (01) : 91 - 99
  • [6] Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia
    Xu, Meng
    Wu, Shuangshuang
    Wang, Yue
    Zhao, Yundong
    Wang, Ximin
    Wei, Changhong
    Liu, Xueying
    Hao, Feng
    Hu, Cheng
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] High dose methotrexate in paediatric acute lymphoblastic leukemia: impact of the pharmacogenetic polymorphisms of RFC1, MDR1 and MRP2 on plasma concentrations
    de Beaumais, T. Adam
    Fakhoury, M.
    Medard, Y.
    Azoughah, S.
    Zhang, D.
    Yakouben, K.
    Jacqz-Aigrain, E.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 55 - 55
  • [8] Effects of thymidylate synthase polymorphisms on toxicities associated with high-dose methotrexate in childhood acute lymphoblastic leukemia
    Abrar Al-Sheikh
    Al-Motassem Yousef
    Daniah Alshamaseen
    Rand Farhad
    [J]. Cancer Chemotherapy and Pharmacology, 2021, 87 : 379 - 385
  • [9] Effects of thymidylate synthase polymorphisms on toxicities associated with high-dose methotrexate in childhood acute lymphoblastic leukemia
    Al-Sheikh, Abrar
    Yousef, Al-Motassem
    Alshamaseen, Daniah
    Farhad, Rand
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (03) : 379 - 385
  • [10] High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: Lack of relation between serum methotrexate concentration and creatinine clearance
    Joannon, P
    Oviedo, I
    Campbell, M
    Tordecilla, J
    [J]. PEDIATRIC BLOOD & CANCER, 2004, 43 (01) : 17 - 22
12345